OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
Carolina M. Perdomo, Jorge M. Núñez‐Córdoba, Ana Ezponda, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Carolina M. Perdomo, Jorge M. Núñez‐Córdoba, Ana Ezponda, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Showing 7 citing articles:
From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
Andrea Boccatonda, Lorenzo Andreetto, Damiano D’Ardes, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 883-883
Open Access | Times Cited: 61
Andrea Boccatonda, Lorenzo Andreetto, Damiano D’Ardes, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 883-883
Open Access | Times Cited: 61
Towards an adiposity-related disease framework for the diagnosis and management of obesities
Carolina M. Perdomo, Icíar Avilés-Olmos, Dror Dicker, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 5, pp. 795-807
Open Access | Times Cited: 22
Carolina M. Perdomo, Icíar Avilés-Olmos, Dror Dicker, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 5, pp. 795-807
Open Access | Times Cited: 22
Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
Kristine Griffett, Thomas P. Burris
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 19
Kristine Griffett, Thomas P. Burris
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 19
Hepatic Steatosis and High-Risk Coronary Plaque
Sara Sukudom, Jason Wee, G. Huangfu, et al.
JACC. Cardiovascular imaging (2024) Vol. 17, Iss. 11, pp. 1392-1394
Closed Access | Times Cited: 3
Sara Sukudom, Jason Wee, G. Huangfu, et al.
JACC. Cardiovascular imaging (2024) Vol. 17, Iss. 11, pp. 1392-1394
Closed Access | Times Cited: 3
FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease
Gabriela Neira, Sara Becerril, Víctor Valentí, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 9, pp. 2221-2233
Open Access | Times Cited: 3
Gabriela Neira, Sara Becerril, Víctor Valentí, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 9, pp. 2221-2233
Open Access | Times Cited: 3
Arterial stiffness progression in metabolic dysfunction–associated fatty liver disease subtypes: A prospective cohort study
Lei Liu, Yufu Zhou, Shuwen Deng, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 8, pp. 1890-1900
Closed Access | Times Cited: 2
Lei Liu, Yufu Zhou, Shuwen Deng, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 8, pp. 1890-1900
Closed Access | Times Cited: 2
Community Series - Liver Fibrosis and MAFLD: from Molecular Aspects to Novel Pharmacological Strategies, Volume II
Frontiers research topics (2024)
Open Access
Frontiers research topics (2024)
Open Access
